HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production

Journal of Leukocyte Biology

Volumn 99, Issue 3, 2016, Pages 495-503

  Harwood, Noah M K ^a   Golden Mason, Lucy ^a   Cheng, Linling ^a   Rosen, Hugo R ^a   Mengshol, John A ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Exosome; JFH 1; Non classical monocyte

Indexed keywords

CD14 ANTIGEN; ECALECTIN; GAMMA INTERFERON; MESSENGER RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; GALECTIN; LGALS9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL MATURATION; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOSOME; EXOSOME; FLOW CYTOMETRY; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNOREGULATION; LIVER CELL; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REPLICON CELL; VIRION; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; EXOSOMES; GALECTINS; HEPATITIS C; HEPATOCYTES; HUMANS; MACROPHAGES; MONOCYTES; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 84961238408     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.5A1214-582R     Document Type: Article

References (52)

1. Rosen, H. R. (2011) Clinical practice. Chronic hepatitis C infection. N. Engl. J. Med. 364, 2429-2438.
2. Rosen, H. R. (2013) Emerging concepts in immunity to hepatitis C virus infection. J. Clin. Invest. 123, 4121-4130.
3. Mengshol, J. A., Golden-Mason, L., Castelblanco, N., Im, K. A., Dillon, S. M., Wilson, C. C., Rosen, H. R.; Virahep-C Study Group. (2009) Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes. Gut 58, 964-973.
4. Mengshol, J. A., Golden-Mason, L., Rosen, H. R. (2007) Mechanisms of disease: HCV-induced liver injury. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 622-634.
5. Golden-Mason, L., Palmer, B. E., Kassam, N., Townshend-Bulson, L., Livingston, S., McMahon, B. J., Castelblanco, N., Kuchroo, V., Gretch, D. R., Rosen, H. R. (2009) Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83, 9122-9130.
6. McMahan, R. H., Golden-Mason, L., Nishimura, M. I., McMahon, B. J., Kemper, M., Allen, T. M., Gretch, D. R., Rosen, H. R. (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120, 4546-4557.
7. Rabinovich, G. A., Toscano, M. A. (2009) Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 9, 338-352.
8. Haining, W. N. (2012) Thinking inside the box: how T cell inhibitory receptors signal. Nat. Med. 18, 1338-1339.
9. Johnson, J. L., Jones, M. B., Ryan, S. O., Cobb, B. A. (2013) The regulatory power of glycans and their binding partners in immunity. Trends Immunol. 34, 290-298.
10. Rabinovich, G. A., Croci, D. O. (2012) Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer. Immunity 36, 322-335.
11. Sánchez-Fueyo, A., Tian, J., Picarella, D., Domenig, C., Zheng, X. X., Sabatos, C. A., Manlongat, N., Bender, O., Kamradt, T., Kuchroo, V. K., Gutiérrez-Ramos, J. C., Coyle, A. J., Strom, T. B. (2003) Tim-3 inhibits T helper type 1-mediated auto-and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4, 1093-1101.
12. Mengshol, J. A., Golden-Mason, L., Arikawa, T., Smith, M., Niki, T., McWilliams, R., Randall, J. A., McMahan, R., Zimmerman, M. A., Rangachari, M., Dobrinskikh, E., Busson, P., Polyak, S. J., Hirashima, M., Rosen, H. R. (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PLoS One 5, e9504.
13. Liberal, R., Grant, C. R., Holder, B. S., Ma, Y., Mieli-Vergani, G., Vergani, D., Longhi, M. S. (2012) The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway. Hepatology 56, 677-686.
14. Li, H., Wu, K., Tao, K., Chen, L., Zheng, Q., Lu, X., Liu, J., Shi, L., Liu, C., Wang, G., Zou, W. (2012) Tim-3/galectin-9 signaling pathway mediates T cell dysfunction and predicts poor prognosis in patients with HBV-associated hepatocellular carcinoma. Hepatology 56, 1342-1351.
15. Golden-Mason, L., McMahan, R. H., Strong, M., Reisdorph, R., Mahaffey, S., Palmer, B. E., Cheng, L., Kulesza, C., Hirashima, M., Niki, T., Rosen, H. R. (2013) Galectin-9 functionally impairs natural killer cells in humans and mice. J. Virol. 87, 4835-4845.
16. Sehrawat, S., Reddy, P. B., Rajasagi, N., Suryawanshi, A., Hirashima, M., Rouse, B. T. (2010) Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6, e1000882.
17. Reddy, P. B., Sehrawat, S., Suryawanshi, A., Rajasagi, N. K., Mulik, S., Hirashima, M., Rouse, B. T. (2011) Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J. Immunol. 187, 5745-5755.
18. Nebbia, G., Peppa, D., Schurich, A., Khanna, P., Singh, H. D., Cheng, Y., Rosenberg, W., Dusheiko, G., Gilson, R., ChinAleong, J., Kennedy, P., Maini, M. K. (2012) Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 7, e47648.
19. Sharma, S., Sundararajan, A., Suryawanshi, A., Kumar, N., Veiga-Parga, T., Kuchroo, V. K., Thomas, P. G., Sangster, M. Y., Rouse, B. T. (2011) T cell immunoglobulin and mucin protein-3 (Tim-3)/galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA 108, 19001-19006.
20. Jost, S., Moreno-Nieves, U. Y., Garcia-Beltran, W. F., Rands, K., Reardon, J., Toth, I., Piechocka-Trocha, A., Altfeld, M., Addo, M. M. (2013) Dysregulated Tim-3 expression on natural killer cells is associated with increased galectin-9 levels in HIV-1 infection. Retrovirology 10, 74.
21. Zhang, Z. Y., Dong, J. H., Chen, Y. W., Wang, X. Q., Li, C. H., Wang, J., Wang, G. Q., Li, H. L., Wang, X. D. (2012) Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma. Asian Pac. J. Cancer Prev. 13, 2503-2509.
22. Kato, T., Date, T., Murayama, A., Morikawa, K., Akazawa, D., Wakita, T. (2006) Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1, 2334-2339.
23. Abeles, R. D., McPhail, M. J., Sowter, D., Antoniades, C. G., Vergis, N., Vijay, G. K., Xystrakis, E., Khamri, W., Shawcross, D. L., Ma, Y., Wendon, J. A., Vergani, D. (2012) CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/CD16 (pos) monocytes in acute liver failure. Cytometry A 81, 823-834.
24. Belge, K. U., Dayyani, F., Horelt, A., Siedlar, M., Frankenberger, M., Frankenberger, B., Espevik, T., Ziegler-Heitbrock, L. (2002) The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 168, 3536-3542.
25. Zhang, J. Y., Zou, Z. S., Huang, A., Zhang, Z., Fu, J. L., Xu, X. S., Chen, L. M., Li, B. S., Wang, F. S. (2011) Hyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B. PLoS One 6, e17484.
26. Dufner-Beattie, J., O'Guin, A., O'Guin, S., Briley, A., Wang, B., Balsarotti, J., Roth, R., Starkey, G., Slomczynska, U., Noueiry, A., Olivo, P. D., Rice, C. M. (2014) Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B. Antimicrob. Agents Chemother. 58, 3399-3410.
27. Lacey, D. C., Achuthan, A., Fleetwood, A. J., Dinh, H., Roiniotis, J., Scholz, G. M., Chang, M. W., Beckman, S. K., Cook, A. D., Hamilton, J. A. (2012) Defining GM-CSF-and macrophage-CSF-dependent macrophage responses by in vitro models. J. Immunol. 188, 5752-5765.
28. Fleetwood, A. J., Lawrence, T., Hamilton, J. A., Cook, A. D. (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178, 5245-5252.
29. Livak, K. J., Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(2Delta Delta C(T)) method. Methods 25, 402-408.
30. Giugliano, S., Kriss, M., Golden-Mason, L., Dobrinskikh, E., Stone, A. E., Soto-Gutierrez, A., Mitchell, A., Khetani, S. R., Yamane, D., Stoddard, M., Li, H., Shaw, G. M., Edwards, M. G., Lemon, S. M., Gale, Jr., M., Shah, V. H., Rosen, H. R. (2015) Hepatitis C virus infection induces autocrine interferon signaling by human liver endothelial cells and release of exosomes, which inhibits viral replication. Gastroenterology 148, 392-402 e13.
31. Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., Nagy, L. E. (2013) Kupffer cells in the liver. Compr. Physiol. 3, 785-797.
32. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., Chisari, F. V. (2005) Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. USA 102, 9294-9299.
33. Dolganiuc, A., Norkina, O., Kodys, K., Catalano, D., Bakis, G., Marshall, C., Mandrekar, P., Szabo, G. (2007) Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection. Gastroenterology 133, 1627-1636.
34. Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., Wakita, T. (2003) Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 125, 1808-1817.
35. Dreux, M., Garaigorta, U., Boyd, B., Décembre, E., Chung, J., Whitten-Bauer, C., Wieland, S., Chisari, F. V. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570.
36. Zarember, K. A., Godowski, P. J. (2002) Tissue expression of human Tolllike receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168, 554-561.
37. Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., Barr, P. J. (1991) Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88, 2451-2455.
38. Targett-Adams, P., Boulant, S., McLauchlan, J. (2008) Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J. Virol. 82, 2182-2195.
39. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., Akira, S. (2002) Small anti-viral compounds activate immune cells via the TLR7 MyD882dependent signaling pathway. Nat. Immunol. 3, 196-200.
40. Forsbach, A., Nemorin, J. G., Montino, C., Muller, C., Samulowitz, U., Vicari, A. P., Jurk, M., Mutwiri, G. K., Krieg, A. M., Lipford, G. B., Vollmer, J. (2008) Identification of RNA sequence motifs stimulating sequencespecific TLR8-dependent immune responses. J. Immunol. 180, 3729-3738.
41. Maess, M. B., Sendelbach, S., Lorkowski, S. (2010) Selection of reliable reference genes during THP-1 monocyte differentiation into macrophages. BMC Mol. Biol. 11, 90.
42. Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., Gale, Jr., M. (2013) IL-1b production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330.
43. Shrivastava, S., Mukherjee, A., Ray, R., Ray, R. B. (2013) Hepatitis C virus induces interleukin-1b (IL-1b)/IL-18 in circulatory and resident liver macrophages. J. Virol. 87, 12284-12290.
44. Stoorvogel, W. (2012) Functional transfer of microRNA by exosomes. Blood 119, 646-648.
45. El Andaloussi, S., Mäger, I., Breakefield, X. O., Wood, M. J. (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov. 12, 347-357.
46. Momen-Heravi, F., Bala, S., Bukong, T., Szabo, G. (2014) Exosomemediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine (Lond.) 10, 1517-1527.
47. Heydtmann, M. (2009) Macrophages in hepatitis B and hepatitis C virus infections. J. Virol. 83, 2796-2802.
48. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., Bauer, S. (2004) Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526-1529.
49. Tanji, H., Ohto, U., Shibata, T., Miyake, K., Shimizu, T. (2013) Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands. Science 339, 1426-1429.
50. Zimmermann, H. W., Seidler, S., Nattermann, J., Gassler, N., Hellerbrand, C., Zernecke, A., Tischendorf, J. J., Luedde, T., Weiskirchen, R., Trautwein, C., Tacke, F. (2010) Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis. PLoS One 5, e11049.
51. Tacke, F., Randolph, G. J. (2006) Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211, 609-618.
52. Coquillard, G., Patterson, B. K. (2009) Determination of hepatitis C virusinfected, monocyte lineage reservoirs in individuals with or without HIV coinfection. J. Infect. Dis. 200, 947-954.